Abstract 4366572: Impact of Type 2 Myocardial Infarction in Diabetic Ketoacidosis: Insights from a National Cohort

I Ifeanyi Momodu (Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States) S Shubhadarshini Pawar R Ricardo Antonio Rodriguez Mejia (Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States) N Nikita Patil (Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States) T Thirumala Keerthi Chandrika Kammaripalle (Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States) H Humza Rana (Cape Fear Valley Medical Center, Fayetteville , North Carolina, United States) E Eric Acker (Cape Fear Valley Health, Fayetteville, North Carolina, United States) A Arun Raghav Mahankali Sridhar (University of Washington, Bellevue, Washington, United States)

Abstract

Background: Diabetic ketoacidosis (DKA) generates profound metabolic derangements that can lead to myocardial oxygen supply-demand imbalance, predisposing patients to Type 2 myocardial infarction (MI). However, the prognostic significance of Type 2 MI in the setting of DKA remains poorly defined. Methods: We analyzed adult hospitalizations with a primary diagnosis of DKA using the Nationwide Readmissions Database (2018–2022). Patients were stratified by the presence of a secondary diagnosis of Type 2 MI. To minimize confounding, 1:1 propensity score matching was performed, balancing for demographics, comorbidities, and hospital characteristics. Outcomes included in-hospital mortality, discharge to a skilled nursing facility (SNF), total hospitalization cost, length of stay (LOS), and 30-day all-cause readmissions. Associations were assessed using multivariable logistic and negative binomial regression models. Results: Among 448,542 DKA hospitalizations, 5,824 (1.3%) were complicated by Type 2 MI. After matching, patients with Type 2 MI exhibited significantly higher in-hospital mortality compared with those without Type 2 MI (3.5% vs. 1.9%; adjusted odds ratio [aOR], 1.85; 95% confidence interval [CI], 1.46–2.35; p<0.001). Type 2 MI was also associated with increased discharge to SNF (18.9% vs. 16.8%; aOR, 1.24; 95% CI, 1.12–1.37; p<0.001), 58% greater hospitalization costs (adjusted coefficient, 0.42; 95% CI, 0.35–0.49; p<0.001), and 72% longer LOS (adjusted coefficient, 0.28; 95% CI, 0.25–0.32; p<0.001). Patients with Type 2 MI had a higher burden of cardiovascular comorbidities, including coronary artery disease (38.5%), prior MI (12.5%), and chronic kidney disease (38.9%). Despite higher acuity, 30-day readmission rates were paradoxically lower in the Type 2 MI group (0.9% vs. 1.5%; aOR, 0.64; 95% CI, 0.45–0.92; p=0.01). Conclusions: In a large, nationally representative cohort, Type 2 MI during DKA hospitalization was independently associated with nearly twofold higher in-hospital mortality and substantially increased resource utilization. These findings highlight the clinical relevance of early recognition and proactive management of myocardial injury in patients with DKA.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (8)

I

Ifeanyi Momodu

Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States

S

Shubhadarshini Pawar

R

Ricardo Antonio Rodriguez Mejia

Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States

N

Nikita Patil

Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States

T

Thirumala Keerthi Chandrika Kammaripalle

Cape Fear Valley Medical Center, Fayetteville, North Carolina, United States

H

Humza Rana

Cape Fear Valley Medical Center, Fayetteville , North Carolina, United States

E

Eric Acker

Cape Fear Valley Health, Fayetteville, North Carolina, United States

A

Arun Raghav Mahankali Sridhar

University of Washington, Bellevue, Washington, United States